TPW
UTHR icon

Talon Private Wealth’s United Therapeutics UTHR Stock Holding History

Talon Private Wealth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.04M Buy
+5,123
New +$2.55M 0.4% 49
2025
Q2 		$1.73M Buy
6,034
+288
+5% +$86.1K 0.24% 78
2025
Q1 		$1.79M Buy
5,746
+5,649
+5,824% +$1.94M 0.24% 73
2024
Q4 		$34.2K Buy
+97
New +$35.7K 0.01% 171

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Talon Private Wealth's UTHR Position: Q1 2026 in Review

Talon Private Wealth opened a new position in United Therapeutics (UTHR) in Q1 2026: 5,123 shares worth $3.04M. The stake represents 0.4% of the portfolio and ranks #49 among its holdings. This is a return to the name: Talon Private Wealth previously reported a position in UTHR as recently as Q2 2025.

Talon Private Wealth first reported a position in UTHR in Q4 2024 and has held it in 4 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Talon Private Wealth held 5,123 shares of United Therapeutics worth $3.04M as of Q1 2026.
  • United Therapeutics was a new Talon Private Wealth position in Q1 2026.
  • United Therapeutics made up 0.4% of Talon Private Wealth's portfolio in Q1 2026, its #49 holding.
  • Talon Private Wealth first reported a position in United Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Talon Private Wealth's 13F filing for Q1 2026, filed 18 May 2026.